The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA)

Salah Ghabri, Erwan Autin, Anne-Isabelle Poullié, Jean Michel Josselin

Open source

DOI
10.1007/s40273-017-0602-5
Published
2017-12-15
Container
PharmacoEconomics
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40273-017-0602-5,
  title = {The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA)},
  author = {Salah Ghabri and Erwan Autin and Anne-Isabelle Poullié and Jean Michel Josselin},
  year = {2017},
  journal = {PharmacoEconomics},
  doi = {10.1007/s40273-017-0602-5},
  url = {https://doi.org/10.1007/s40273-017-0602-5}
}

RIS

TY  - JOUR
TI  - The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA)
AU  - Salah Ghabri
AU  - Erwan Autin
AU  - Anne-Isabelle Poullié
AU  - Jean Michel Josselin
PY  - 2017
JO  - PharmacoEconomics
DO  - 10.1007/s40273-017-0602-5
UR  - https://doi.org/10.1007/s40273-017-0602-5
ER  - 

APA

Ghabri, S., Autin, E., Poullié, A., & Josselin, J. M. (2017). The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA). PharmacoEconomics. https://doi.org/10.1007/s40273-017-0602-5

Source records